| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mairead Doyle, Aoife Ni Chorcorain, Eleanor Griffith, Tim Trimble, Eadbard O'Callagha. Obsessive compulsive symptoms in patients with Schizophrenia on Clozapine and with Obsessive Compulsive disorder: a comparison study. Comprehensive psychiatry. vol 55. issue 1. 2014-08-11. PMID:24209980. |
overall fourteen (22%) of the schizophrenia treated with clozapine group had clinically significant total oci scores. |
2014-08-11 |
2023-08-12 |
human |
| Bruna Mara Machado Ribeiro, Marta Regina Santos do Carmo, Rosemayre Souza Freire, Nayrton Flávio Moura Rocha, Vládia Célia Moreira Borella, Antonio Teles de Menezes, Aline Santos Monte, Patrícia Xavier Lima Gomes, Francisca Cléa Florenço de Sousa, Mariana Lima Vale, David Freitas de Lucena, Clarissa Severino Gama, Danielle Macêd. Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine. Schizophrenia research. vol 151. issue 1-3. 2014-07-29. PMID:24257517. |
evidences for a progressive microglial activation and increase in inos expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine. |
2014-07-29 |
2023-08-12 |
rat |
| Bruna Mara Machado Ribeiro, Marta Regina Santos do Carmo, Rosemayre Souza Freire, Nayrton Flávio Moura Rocha, Vládia Célia Moreira Borella, Antonio Teles de Menezes, Aline Santos Monte, Patrícia Xavier Lima Gomes, Francisca Cléa Florenço de Sousa, Mariana Lima Vale, David Freitas de Lucena, Clarissa Severino Gama, Danielle Macêd. Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine. Schizophrenia research. vol 151. issue 1-3. 2014-07-29. PMID:24257517. |
taken together these results give further evidences for a neuroprogressive etiology and course of schizophrenia and that clozapine may partly alleviate this process. |
2014-07-29 |
2023-08-12 |
rat |
| John Lally, Jennifer Brook, Thomas Dixon, Fiona Gaughran, Sukhi Shergill, Narbeh Melikian, James H MacCab. Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series. Therapeutic advances in psychopharmacology. vol 4. issue 3. 2014-07-24. PMID:25057344. |
clozapine is the most efficacious treatment for treatment-resistant schizophrenia; however its use can be limited by intolerability. |
2014-07-24 |
2023-08-13 |
Not clear |
| Nuwan Galappathie, Sobia Kha. Clozapine-associated pneumonia and respiratory arrest secondary to severe constipation. Medicine, science, and the law. vol 54. issue 2. 2014-07-07. PMID:24052002. |
clozapine is often the drug of choice within patients suffering from treatment-resistant paranoid schizophrenia. |
2014-07-07 |
2023-08-12 |
Not clear |
| Evangelia Eirini Tsermpini, Konstantinos Assimakopoulos, Marina Bartsakoulia, Gregoris Iconomou, Eleni Merkouri Papadima, Konstantinos Mitropoulos, Alessio Squassina, George P Patrino. Individualizing clozapine and risperidone treatment for schizophrenia patients. Pharmacogenomics. vol 15. issue 1. 2014-07-07. PMID:24329194. |
individualizing clozapine and risperidone treatment for schizophrenia patients. |
2014-07-07 |
2023-08-12 |
Not clear |
| Benjamin W J Spencer, Barbara Prainsack, Dan Rujescu, Ina Giegling, David A Collier, Fiona Gaughran, James H MacCabe, Cathy L Barr, Engilbert Sigurdsson, Henrik Stovring, Anil K Malhotra, Sarah R Curra. Opening Pandora's box in the UK: a hypothetical pharmacogenetic test for clozapine. Pharmacogenomics. vol 14. issue 15. 2014-06-25. PMID:24236489. |
clozapine is a uniquely efficacious antipsychotic drug in treatment-resistant schizophrenia. |
2014-06-25 |
2023-08-12 |
Not clear |
| S van Zuilekom, H J Gijsma. [A patient on clozapine in the general hospital: the need for discussion between specialists from different disciplines and for close monitoring of the patient's plasma level]. Tijdschrift voor psychiatrie. vol 55. issue 12. 2014-06-24. PMID:24366834. |
a 49-year-old man being treated with clozapine for schizophrenia was prescribed ciprofloxacin because of bile spill following cholecystectomy. |
2014-06-24 |
2023-08-12 |
Not clear |
| Basel A Abdel-Wahab, Metwally E Metwally, Mohamed M El-khawanki, Alaa M Hashi. Protective effect of captopril against clozapine-induced myocarditis in rats: role of oxidative stress, proinflammatory cytokines and DNA damage. Chemico-biological interactions. vol 216. 2014-06-24. PMID:24709159. |
clozapine (clz) is the most effective therapeutic alternative in the treatment of resistant schizophrenia. |
2014-06-24 |
2023-08-13 |
rat |
| P De Domenico, A E Di Rosa, A A Dagostino, G Martino, M Meduri, E Spin. The effect of clozapine on aggressive behaviour in patients with chronic schizophrenia. International journal of psychiatry in clinical practice. vol 3. issue 1. 2014-06-21. PMID:24945067. |
the effect of clozapine on aggressive behaviour in patients with chronic schizophrenia. |
2014-06-21 |
2023-08-13 |
Not clear |
| J G Rasmusse. Drug treatments for schizophrenia - past, present and future. International journal of psychiatry in clinical practice. vol 1. issue 4. 2014-06-21. PMID:24946188. |
the first atypical antipsychotic, clozapine, has been restricted to use in treatment-resistant schizophrenia because of an association with agranwlocytosis. |
2014-06-21 |
2023-08-13 |
Not clear |
| G Joffe, J Rybak, M Burkin, D Burkin, B Appelberg, M Joffe, R Gädeke, R Rimo. Clozapine response in early treatment-resistant schizophrenia. International journal of psychiatry in clinical practice. vol 1. issue 4. 2014-06-21. PMID:24946192. |
clozapine response in early treatment-resistant schizophrenia. |
2014-06-21 |
2023-08-13 |
Not clear |
| Pei-Xian Mao, Yi-Lang Tang, Zhi-Min Wang, Feng Jiang, Charles F Gillespie, Zhuo-Ji Ca. Antipsychotic drug use in 503 Chinese inpatients with schizophrenia. International journal of psychiatry in clinical practice. vol 11. issue 1. 2014-06-20. PMID:24941273. |
conventional antipsychotics and clozapine constitute the current mainstream of schizophrenia treatment in china where a lower percentage of patients receive sgas other than clozapine than in developed countries. |
2014-06-20 |
2023-08-13 |
Not clear |
| b' J Hor\\xc3\\xa1\\xc4\\x8dek J Libiger C H\\xc3\\xb6schl K Borzova I Hendrychov\\xc3\\xa. Clozapine-induced concordant agranulocytosis in monozygotic twins. International journal of psychiatry in clinical practice. vol 5. issue 1. 2014-06-19. PMID:24937002.' |
our case report of twins afflicted synchronously with schizophrenia and later with agranulocytosis after clozapine is of interest because it suggests that genetic factors may participate not only in timing of onset of schizophrenia, but also in the emergence and timing of agranulocytosis in response to clozapine treatment. |
2014-06-19 |
2023-08-13 |
Not clear |
| Wai Hong Man, Maarten Ten Berg, Ingeborg Wilting, Albert Huisman, Wiepke Cahn, Jan Willem Douma, Hanneke den Breeijen, Eibert R Heerdink, Toine Egberts, Wouter van Soling. Fluorescence of neutrophil granulocytes as a biomarker for clozapine use. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 23. issue 11. 2014-06-17. PMID:24074821. |
non-adherence to medication is a major issue in the treatment of schizophrenia in general and in particular for those treated with clozapine. |
2014-06-17 |
2023-08-12 |
Not clear |
| M V Cheine, K Wahlbeck, M Rimó. Pharmacological treatment of schizophrenia resistant to first-line treatment: a critical systematic review and meta-analysis. International journal of psychiatry in clinical practice. vol 3. issue 3. 2014-06-17. PMID:24927201. |
on the basis of the methodologically sound studies included, we conclude that only clozapine has proved to be clinically effective in the treatment of refractory schizophrenia. |
2014-06-17 |
2023-08-13 |
Not clear |
| Giuseppe Guaiana, Philip Tyson, Ann Margaret Mortime. The Rivermead Behavioural Memory Test can predict social functioning among schizophrenic patients treated with clozapine. International journal of psychiatry in clinical practice. vol 8. issue 4. 2014-06-17. PMID:24930553. |
objective the aim of this study was to find out whether clinical symptoms, such as positive and negative symptoms, or cognitive problems, such as impairment in memory, are predictive of social outcome among patients with schizophrenia and treated with clozapine in the long-term. |
2014-06-17 |
2023-08-13 |
human |
| Giuseppe Guaiana, Philip Tyson, Ann Margaret Mortime. The Rivermead Behavioural Memory Test can predict social functioning among schizophrenic patients treated with clozapine. International journal of psychiatry in clinical practice. vol 8. issue 4. 2014-06-17. PMID:24930553. |
methods twelve subjects with a dsm-iii-r diagnosis of schizophrenia treated with clozapine were recruited from an inpatient rehabilitation psychiatry unit. |
2014-06-17 |
2023-08-13 |
human |
| R M Balen, R M Procyshy. Valproic acid for seizure prophylaxis during clozapine therapy: Where's the evidence? International journal of psychiatry in clinical practice. vol 3. issue 4. 2014-06-14. PMID:24921227. |
clozapine, a dibenzodiazepine derivative, is the prototype atypical antipsychotic indicated for treatment-resistant patients with schizophrenia. |
2014-06-14 |
2023-08-13 |
Not clear |
| S Mennickent, A Sobarzo, M Vega, M de Diego, G Godoy, P Rioseco, L Saavedr. Determination of clozapine in serum of patients with schizophrenia as a measurement of medication compliance. International journal of psychiatry in clinical practice. vol 14. issue 1. 2014-06-12. PMID:24917231. |
determination of clozapine in serum of patients with schizophrenia as a measurement of medication compliance. |
2014-06-12 |
2023-08-13 |
human |